FDA Adverse Event Death Summary report: N

6F ANGIO-SEAL VASCULAR CLOSURE DEVICE STS

MDR report key: 516621 · Received March 18, 2004

Report

Report Number
2182269-2004-00049
Event Type
Death
Date Received
March 18, 2004
Report Date
March 18, 2004
Manufacturer
ST. JUDE MEDICAL, DAIG DIVISION, INC.
Product Code
MGB
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

IT WAS REPORTED FOLLOWING A STENT PLACEMENT AND PRE-DEPLOYMENT FEMORAL ANGIOGRAM, AN ANGIO-SEAL DEVICE WAS USED TO SEAL THE ARTERIOTOMY SITE. THE PT RECEIVED HEPARIN AT THE END OF THE PROCEDURE PER HOSPITAL PROTOCOL. THE PT AMBULATED APPROXIMATELY THREE HOURS LATER. THREE HOURS FOLLOWING INITIAL AMBULATION, THE PT COMPLAINED OF NOT FEELING WELL AND REPORTEDLY HEARD A "POP" AT THE GROIN SITE. PT THEN COMPLAINED OF CHEST PAIN AND BLEEDING WAS NOTED FROM THE GROIN SITE. MANUAL PRESSURE AND A FEMOSTOP WERE APPLIED; HEMOSTASIS WAS NOT ACHIEVED. THE PT BECAME HYPOTENSIVE, SUFFERED A MYOCARDIAL INFARCTION, AND WENT INTO COMPLETE HEART BLOCK. ATTEMPTS AT TEMPORARY PACING WERE UNSUCCESSFUL AND THE PT EXPIRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 6F ANGIO-SEAL VASCULAR CLOSURE DEVICE STS 6F ANGIO-SEAL STS MGB ST. JUDE MEDICAL, DAIG DIVISION, INC. NA 1046933

Patients

Seq Age Sex Outcome Treatment
1 61 YR Death 1. HEPARIN,| 2. REOPRO (DOSE UNKNOWN) 2004.